Trade-Ideas LLC identified




) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Electromed as such a stock due to the following factors:

  • ELMD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $2.7 million.
  • ELMD has traded 184,873 shares today.
  • ELMD is trading at 40.57 times the normal volume for the stock at this time of day.
  • ELMD is trading at a new high 17.02% above yesterday's close.

'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ELMD with the Ticky from Trade-Ideas. See the FREE profile for ELMD NOW at Trade-Ideas

More details on ELMD:

TST Recommends

Electromed, Inc. designs, develops, manufactures, markets, and sells airway clearance therapy products in the United States and internationally. ELMD has a PE ratio of 21. Currently there is 1 analyst that rates Electromed a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Electromed has been 222,400 shares per day over the past 30 days. Electromed has a market cap of $33.6 million and is part of the health care sector and health services industry. The stock has a beta of 2.45 and a short float of 0.4% with 0.02 days to cover. Shares are up 122.6% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates Electromed as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing.

Highlights from the ratings report include:

  • Powered by its strong earnings growth of 160.00% and other important driving factors, this stock has surged by 79.03% over the past year, outperforming the rise in the S&P 500 Index during the same period. Although ELMD had significant growth over the past year, our hold rating indicates that we do not recommend additional investment in this stock at the current time.
  • ELECTROMED INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, ELECTROMED INC turned its bottom line around by earning $0.13 versus -$0.15 in the prior year. This year, the market expects an improvement in earnings ($0.32 versus $0.13).
  • Net operating cash flow has significantly increased by 160.18% to $0.86 million when compared to the same quarter last year. In addition, ELECTROMED INC has also vastly surpassed the industry average cash flow growth rate of 11.22%.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market on the basis of return on equity, ELECTROMED INC has outperformed in comparison with the industry average, but has underperformed when compared to that of the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.